Subgroups | Studies (participants) | Incidence of mortality (%), (95 CI) | Heterogeneity (I²), P | Coefficient (95 CI) | Subgroup differences (P) | |
---|---|---|---|---|---|---|
Severity of AKI | Â | Â | Â | Â | Â | Â |
AKI stage 1 | 26 (14843) | 8.19 (5.65, 10.73) | 97.8, < 0.001 | Reference |  | |
AKI stage 2 | 20 (8044) | 13.44 (8.69, 18.19) | 97.4, < 0.001 | 0.049 (-0.015, 0.113) | 0.136 | |
AKI stage 3 | 21 (8487) | 27.78 (21.82, 33.74) | 96.8, < 0.001 | 0.187 (0.123, 0.252) | < 0.001 | |
AKI stage 1 and 2 | 20 (21780) | 12.54 (8.05, 17.02) | 99.3, < 0.001 | 0.040 (-0.023, 0.104) | 0.211 | |
AKI stage 2 and 3 | 28 (17040) | 23.50 (18.62, 28.39) | 98.2, < 0.001 | 0.146 (0.088, 0.205) | < 0.001 | |
Age | Â | Â | Â | Â | Â | Â |
< 1 month | 18 (35190) | 22.81 (16.84, 20.75) | 99.57, < 0.001 | Reference |  | |
> 1 month | 34 (93070) | 16.56 (12.37, 20.75) | 99.78, < 0.001 | -0.062 (-0.138, 0.013) | 0.107 | |
Study design | Â | Â | Â | Â | Â | Â |
Prospective study | 15 (5627) | 19.34 (13.66, 25.03) | 97.67, < 0.001 | Reference |  | |
Retrospective study | 44 (128049) | 17.88 (13.70, 22.07) | 99.90, < 0.001 | -0.016 (-0.096, 0.064) | 0.691 | |
Country income classification (as per gross national income per capita) | Â | Â | Â | Â | ||
Low income | 5 (1443) | 12.31 (5.44, 19.17) | 94.80, < 0.001 | Reference |  | |
Lower-middle income | 1 (200) | Insufficient data | Insufficient data | Insufficient data | Insufficient data | |
Upper-middle income | 12 (29821) | 15.65 (8.87, 22.44) | 99.8, < 0.001 | 0.033 (-0.097, 0.163) | 0.623 | |
High-income | 35 (97956) | 18.88 (14.56, 23.20) | 99.8, < 0.001 | 0.064 (-0.052, 0.181) | 0.279 | |
Region | Â | Â | Â | Â | Â | |
AFR | 5 (1443) | 12.31 (5.44, 19.17) | 94.8, < 0.001 | Reference |  | |
AMR | 28 (92635) | 18.66 (13.12, 24.20) | 99.9, < 0.001 | 0.062 (-0.060, 0.184) | 0.320 | |
EMR | 4 (1295) | 26.69 (21.01, 32.37) | 80.3, < 0.001 | 0.145 (-0.025, 0.315) | 0.095 | |
EUR | 8 (6518) | 17.77 (9.41, 26.13) | 98.5, < 0.001 | 0.054 (-0.090, 0.199) | 0.462 | |
SEAR | 2 (369) | 24.73 (12.13, 37.33) | 87.7, < 0.001 | 0.124 (-0.089, 0.337) | 0.255 | |
WPR | 9 (29340) | 12.64 (6.35, 18.94) | 99.8, < 0.001 | 0.004 (-0.137, 0.145) | 0.956 | |
AKI criteria | Â | Â | Â | Â | Â | |
KDIGO/mKDIGO | 40 (50717) | 16.76 (13.01, 20.51) | 99.6, < 0.001 | Reference |  | |
RIFLE/pRIFLE/nRIFLE | 5 (994) | 22.81 (16.28, 29.34) | 83.5, < 0.001 | 0.059 (-0.068, 0.186) | 0.364 | |
AKIN/mAKIN | 1 (100) | Insufficient data | Insufficient data | Insufficient data | Insufficient data | |
ICD-9/ICD-10 | 6 (54292) | 19.91 (4.05, 35.77) | 100.0, < 0.001 | 0.030 (-0.085, 0.145) | 0.610 | |
Miscellaneous | 8 (27773) | 19.96 (8.15, 31.76) | 99.8, < 0.001 | 0.031 (-0.071, 0.134) | 0.549 | |
AKI criteria based on | Â | Â | Â | Â | Â | |
SCr | 39 (124124) | 18.19 (14.08, 22.30) | 99.9, < 0.001 | Reference |  | |
SCr + UOP | 18 (6376) | 17.31 (11.96, 22.66) | 98.0, < 0.001 | -0.008 (-0.079, 0.063) | 0.831 | |
Predisposing condition | Â | Â | Â | Â | Â | |
Prematurity-related outcomes | 6 (20643) | 25.88 (18.63, 33.13) | 94.9, < 0.001 | Reference |  | |
Sepsis/septic shock | 3 (45946) | 16.06 (11.21, 20.90) | 86.5, < 0.001 | -0.102 (-0.279, 0.076) | 0.262 | |
Infections | 8 (2435) | 14.94 (4.02, 25.86) | 99.4, < 0.001 | -0.112 (-0.248, 0.024) | 0.108 | |
Cardiac surgery | 5 (1274) | 16.27 (9.48, 23.06) | 90.0, < 0.001 | -0.093 (-0.246, 0.061) | 0.235 | |
Non-cardiac surgery | 3 (3358) | 25.98 (-1.48, 53.44) | 99.6, < 0.001 | -0.001 (-0.178, 0.176) | 0.992 | |
ECMO | 2 (768) | 39.54 (17.53, 61.55) | 96.6, < 0.001 | 0.137 (-0.069, 0.344) | 0.193 | |
Mixed etiology | 25 (53178) | 14.61 (10.55, 18.67) | 99.8, < 0.001 | -0.112 (-0.227, 0.003) | 0.056 | |
Miscellaneous a | 8 (6274) | 21.00 (9.03, 32.97) | 99.4, < 0.001 | -0.050 (-0.186, 0.086) | 0.475 |